In English
NIDA

Search

Menu

Medicamentos de prescripción

NIDA’s Dr. Nora Volkow joins President Clinton on Clinton Foundation’s prescription drug abuse panel

Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will join President Bill Clinton, New York dignitaries, and college students from New York University for a panel discussion on prescription drug abuse.


Thoughts of Suicide May Persist Among Nonmedical Prescription Opiate Users

People who use prescription opiates nonmedically are more likely to consider suicide than those who use these medications only appropriately or not at all. A recent NIDA-supported study also disclosed that the risk for suicidal thoughts remains elevated after cessation of use.

Adolescent Cigarette, Alcohol Use Declines as Marijuana Use Rises

Fewer teens are using cigarettes, alcohol, and most illicit drugs, according to NIDA’s latest Monitoring the Future study. Troubling  trends persist in marijuana use, however, and nonmedical prescription drug use remains a concern.

Nota de la Directora

El abuso y uso no médico de medicamentos de prescripción es un problema grave de salud pública en los Estados Unidos. Aunque la mayoría de las personas toman los medicamentos de prescripción de manera responsable, se calcula que unas 52 millones de personas (el 20 por ciento de las personas de 12 años y mayores) han consumido medicamentos de prescripción por razones no médicas al menos una vez en su vida, y los jóvenes tienen una representación importante en este grupo.

Prevention efforts focused on youth reduce prescription abuse into adulthood

Middle school students from small towns and rural communities who received any of three community-based prevention programs were less likely to abuse prescription medications in late adolescence and young adulthood.


Regular marijuana use by teens continues to be a concern

Continued high use of marijuana by the nation's eighth, 10th and 12th graders combined with a drop in perceptions of its potential harms was revealed in this year's Monitoring the Future survey, an annual survey of eighth, 10th, and 12th–graders conducted by researchers at the University of Michi


Q&A: Dr. David Thomas

NIDA Program Officer Dr. David Thomas speaks about the intertwined problems of pain and prescription opioid abuse, as well as the research supported by NIDA and the National Institutes of Health to address these problems.

White House Drug Policy Office and National Institute on Drug Abuse Unveil New Training Materials to Combat National Prescription Drug Abuse Epidemic

Today, the Office of National Drug Control Policy (ONDCP) and the National Institute on Drug Abuse (NIDA) launched a new online learning tool which will provide training for healthcare providers on proper prescribing and patient management practices for patients on opioid analgesics (painkillers)


Few Teens With Prescription Opioid Use Disorders Receive Treatment

Fewer than 12 percent of adolescents who meet diagnostic criteria for prescription opioid abuse or dependence receive any treatment, according to an analysis of data from the 2005 to 2008 National Survey on Drug Use and Health. The most common reason the adolescents gave for not receiving treatment was their lack of perceived need for it.

Pages

Subscribe to RSS - Medicamentos de prescripción

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas